Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling
Keywords: NPM/B23, nucleophosmin/B23; ALL, acute lymphoblastic leukemia; MDR, multidrug resistance; P-gp, P-glycoprotein; ADM, adriamycin; DNR, daunorubicin; CTX, cyclophosphamide; VCR, vincristine; VP16, etoposide; IC50, half inhibitory concentration; RNAi, RNA in